Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Marianne Kristiansen Kringen

59 publications found

Original articles

Wollmann BM, Smith RL, Kringen MK, Ingelman-Sundberg M, Molden E, Størset E (2023)
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism
Br J Clin Pharmacol, 90 (3), 740-747
DOI 10.1111/bcp.15721, PubMed 36960588

Hovd M, Robertsen I, Johnson LK, Krogstad V, Wegler C, Kvitne KE, Kringen MK, Skovlund E, Karlsson C, Andersson S, Artursson P, Sandbu R, Hjelmesæth J, Åsberg A, Jansson-Löfmark R, Christensen H (2023)
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance
Clin Pharmacokinet, 62 (5), 725-735
DOI 10.1007/s40262-023-01235-5, PubMed 36988826

Dietrichs ES, Haslemo T, Kringen MK, Molden E, Solhaug V (2022)
[E.S. Dietrichs et al. respond]
Tidsskr Nor Laegeforen, 142 (16)
DOI 10.4045/tidsskr.22.0665, PubMed 36345638

Lenk HÇ, Løvsletten Smith R, O'Connell KS, Jukić MM, Kringen MK, Andreassen OA, Ingelman-Sundberg M, Molden E (2022)
Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits
Clin Transl Sci, 16 (1), 62-72
DOI 10.1111/cts.13422, PubMed 36152308

Solhaug V, Haslemo T, Kringen MK, Molden E, Dietrichs ES (2022)
Genotyping of patients treated with selective serotonin reuptake inhibitors
Tidsskr Nor Laegeforen, 142 (13)
DOI 10.4045/tidsskr.22.0017, PubMed 36164782

Halvorsen LV, Bergland OU, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Kringen MK, Clasen PE, Haldsrud R, Kjeldsen SE, Rostrup M, Fadl Elmula FEM, Opdal MS, Høieggen A (2022)
Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy
J Am Heart Assoc, 11 (18), e025879
DOI 10.1161/JAHA.121.025879, PubMed 36073648

Bråten LS, Ingelman-Sundberg M, Jukic MM, Molden E, Kringen MK (2022)
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
Clin Transl Sci, 15 (9), 2135-2145
DOI 10.1111/cts.13347, PubMed 35668575

Kvitne KE, Krogstad V, Wegler C, Johnson LK, Kringen MK, Hovd MH, Hertel JK, Heijer M, Sandbu R, Skovlund E, Artursson P, Karlsson C, Andersson S, Andersson TB, Hjelmesaeth J, Åsberg A, Jansson-Löfmark R, Christensen H, Robertsen I (2022)
Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity
Br J Clin Pharmacol, 88 (9), 4121-4133
DOI 10.1111/bcp.15349, PubMed 35404513

Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, Ohldieck C, Druckrey-Fiskaaen KT, Aas C, Løberg EM, Bramness JG, Fadnes LT (2022)
Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations
J Addict Dis, 41 (1), 53-63
DOI 10.1080/10550887.2022.2057140, PubMed 35356868

Datta HK, Kringen MK, Tuck SP, Salpingidou G, Olstad OK, Gautvik KM, Cockell SJ, Gautvik VT, Prediger M, Wu JJ, Birch MA, Reppe S (2022)
Mechanical-Stress-Related Epigenetic Regulation of ZIC1 Transcription Factor in the Etiology of Postmenopausal Osteoporosis
Int J Mol Sci, 23 (6)
DOI 10.3390/ijms23062957, PubMed 35328378

Smith RL, Wollmann BM, Kausberg M, Mæland S, Tveito M, O'Connell K, Molden E, Kringen MK (2022)
Effects of a Novel UGT2B Haplotype and UGT1A4*3 Allele Variants on Glucuronidation of Clozapine In vivo
Curr Drug Metab, 23 (1), 66-72
DOI 10.2174/1389200223666220201152953, PubMed 35105285

Bråten LS, Haslemo T, Jukic MM, Ivanov M, Ingelman-Sundberg M, Molden E, Kringen MK (2021)
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram
Clin Pharmacol Ther, 110 (3), 786-793
DOI 10.1002/cpt.2233, PubMed 33759177

Krogstad V, Peric A, Robertsen I, Kringen MK, Vistnes M, Hjelmesæth J, Sandbu R, Johnson LK, Angeles PC, Jansson-Löfmark R, Karlsson C, Andersson S, Åsberg A, Andersson TB, Christensen H (2020)
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes
J Pharm Sci, 110 (1), 432-437
DOI 10.1016/j.xphs.2020.10.027, PubMed 33091408

Thorén L, Lindh JD, Ackehed G, Kringen MK, Hall P, Bergh J, Molden E, Margolin S, Eliasson E (2020)
Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles
Br J Clin Pharmacol, 87 (3), 1243-1252
DOI 10.1111/bcp.14500, PubMed 32713032

Smith RL, O'Connell K, Athanasiu L, Djurovic S, Kringen MK, Andreassen OA, Molden E (2020)
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits
Transl Psychiatry, 10 (1), 198
DOI 10.1038/s41398-020-00888-1, PubMed 32555152

Lao YE, Molden E, Kringen MK, Annexstad EJ, Saeverud HA, Jacobsen D, Hovda KE (2020)
Fatal liver failure after therapeutic doses of paracetamol in a patient with Duchenne muscular dystrophy and atypical pharmacogenetic profile of drug-metabolizing enzymes
Basic Clin Pharmacol Toxicol, 127 (1), 47-51
DOI 10.1111/bcpt.13389, PubMed 31977139

Kringen MK, Bråten LS, Haslemo T, Molden E (2020)
The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort
J Clin Psychopharmacol, 40 (2), 137-144
DOI 10.1097/JCP.0000000000001174, PubMed 32134850

Krogstad V, Peric A, Robertsen I, Kringen MK, Wegler C, Angeles PC, Hjelmesæth J, Karlsson C, Andersson S, Artursson P, Åsberg A, Andersson TB, Christensen H (2019)
A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity
Drug Metab Dispos, 48 (1), 8-17
DOI 10.1124/dmd.119.087940, PubMed 31685482

Bråten LS, Haslemo T, Jukic MM, Ingelman-Sundberg M, Molden E, Kringen MK (2019)
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients
Neuropsychopharmacology, 45 (3), 570-576
DOI 10.1038/s41386-019-0554-x, PubMed 31649299

Olsen TCR, Rasmussen AR, Kringen MK, Molden E (2019)
A girl of early school-age with no response to opioids during general anaesthesia
Tidsskr. Nor. Laegeforen., 139 (7), 621-623

Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y et al. (2019)
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals
Clin Pharmacol Ther, 105 (6), 1477-1491
DOI 10.1002/cpt.1323, PubMed 30506689

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G (2017)
Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment
Ther Drug Monit, 39 (5), 550-555
DOI 10.1097/FTD.0000000000000437, PubMed 28723731

Reppe S, Lien TG, Hsu YH, Gautvik VT, Olstad OK, Yu R, Bakke HG, Lyle R, Kringen MK, Glad IK, Gautvik KM (2017)
Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women
Epigenetics, 12 (8), 674-687
DOI 10.1080/15592294.2017.1345832, PubMed 28650214

Narum S, Brørs O, Stokland O, Kringen MK (2016)
Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre
BMC Emerg Med, 16 (1), 29
DOI 10.1186/s12873-016-0094-1, PubMed 27485307

Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J (2016)
Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
Epigenetics Chromatin, 9, 21
DOI 10.1186/s13072-016-0070-8, PubMed 27252783

Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
Clin Ther, 37 (7), 1594-9
DOI 10.1016/j.clinthera.2015.04.009, PubMed 25963997

Kringen MK, Stormo C, Berg JP, Terry SF, Vocke CM, Rizvi S, Hendig D, Piehler AP (2015)
Copy number variation in the ATP-binding cassette transporter ABCC6 gene and ABCC6 pseudogenes in patients with pseudoxanthoma elasticum
Mol Genet Genomic Med, 3 (3), 233-7
DOI 10.1002/mgg3.137, PubMed 26029710

Kringen MK (2015)
Analysis of Copy Number Variation by Pyrosequencing® Using Paralogous Sequences
Methods Mol Biol, 1315, 115-21
DOI 10.1007/978-1-4939-2715-9_9, PubMed 26103895

Stormo C, Kringen MK, Lyle R, Olstad OK, Sachse D, Berg JP, Piehler AP (2014)
RNA-sequencing analysis of HepG2 cells treated with atorvastatin
PLoS One, 9 (8), e105836
DOI 10.1371/journal.pone.0105836, PubMed 25153832

Kringen MK, Piehler AP, Grimholt RM, Opdal MS, Haug KB, Urdal P (2014)
Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants
PLoS One, 9 (2), e90248
DOI 10.1371/journal.pone.0090248, PubMed 24587300

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
DOI 10.1007/s40291-013-0031-x, PubMed 23580084

Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK (2013)
Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system
Eur J Clin Pharmacol, 69 (7), 1445-52
DOI 10.1007/s00228-013-1479-7, PubMed 23423243

Stormo C, Kringen MK, Grimholt RM, Berg JP, Piehler AP (2012)
A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus
BMC Mol Biol, 13, 29
DOI 10.1186/1471-2199-13-29, PubMed 22989091

Kringen MK, Stormo C, Grimholt RM, Berg JP, Piehler AP (2012)
Copy number variations of the ATP-binding cassette transporter ABCC6 gene and its pseudogenes
BMC Res Notes, 5, 425
DOI 10.1186/1756-0500-5-425, PubMed 22873774

Evang JA, Berg JP, Casar-Borota O, Lekva T, Kringen MK, Ramm-Pettersen J, Bollerslev J (2011)
Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours
Clin Endocrinol (Oxf), 75 (6), 811-8
DOI 10.1111/j.1365-2265.2011.04109.x, PubMed 21595730

Narum S, Solhaug V, Myhr K, Johansen PW, Brørs O, Kringen MK (2011)
Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system
Br J Clin Pharmacol, 71 (2), 254-62
DOI 10.1111/j.1365-2125.2010.03827.x, PubMed 21219407

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
Reduced platelet function and role of drugs in acute gastrointestinal bleeding
Basic Clin Pharmacol Toxicol, 108 (3), 194-201
DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353

Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
J Biomed Biotechnol, 2011, 739751
DOI 10.1155/2011/739751, PubMed 21127708

Brix TH, Hansen PS, Knudsen GP, Kringen MK, Kyvik KO, Orstavik KH, Hegedüs L (2009)
No link between X chromosome inactivation pattern and simple goiter in females: evidence from a twin study
Thyroid, 19 (2), 165-9
DOI 10.1089/thy.2008.0380, PubMed 19191747

Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
Thromb J, 6, 7
DOI 10.1186/1477-9560-6-7, PubMed 18559094

Ørstavik KH, Kristiansen M, Knudsen GP, Storhaug K, Vege A, Eiklid K, Abrahamsen TG, Smahi A, Steen-Johnsen J (2006)
Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation
Am J Med Genet A, 140 (1), 31-9
DOI 10.1002/ajmg.a.31026, PubMed 16333836

Brix TH, Knudsen GP, Kristiansen M, Kyvik KO, Orstavik KH, Hegedüs L (2005)
High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity
J Clin Endocrinol Metab, 90 (11), 5949-53
DOI 10.1210/jc.2005-1366, PubMed 16105963

Kristiansen M, Knudsen GP, Maguire P, Margolin S, Pedersen J, Lindblom A, Ørstavik KH (2005)
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer
J Med Genet, 42 (11), 877-80
DOI 10.1136/jmg.2005.032433, PubMed 15879497

Kristiansen M, Knudsen GP, Bathum L, Naumova AK, Sørensen TI, Brix TH, Svendsen AJ, Christensen K, Kyvik KO, Ørstavik KH (2005)
Twin study of genetic and aging effects on X chromosome inactivation
Eur J Hum Genet, 13 (5), 599-606
DOI 10.1038/sj.ejhg.5201398, PubMed 15756296

Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH (2003)
X chromosome inactivation in cervical cancer patients
Cancer Genet Cytogenet, 146 (1), 73-6
DOI 10.1016/s0165-4608(03)00152-3, PubMed 14499700

Kristiansen M, Knudsen GP, Tanner SM, McEntagart M, Jungbluth H, Muntoni F, Sewry C, Gallati S, Ørstavik KH, Wallgren-Pettersson C (2003)
X-inactivation patterns in carriers of X-linked myotubular myopathy
Neuromuscul Disord, 13 (6), 468-71
DOI 10.1016/s0960-8966(03)00067-1, PubMed 12899873

Jungbluth H, Sewry CA, Buj-Bello A, Kristiansen M, Ørstavik KH, Kelsey A, Manzur AY, Mercuri E, Wallgren-Pettersson C, Muntoni F (2003)
Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation
Neuromuscul Disord, 13 (1), 55-9
DOI 10.1016/s0960-8966(02)00194-3, PubMed 12467733

Kristiansen M, Knudsen GP, Søyland A, Westvik J, Ørstavik KH (2002)
Phenotypic variation in Melnick-Needles syndrome is not reflected in X inactivation patterns from blood or buccal smear
Am J Med Genet, 108 (2), 120-7
DOI 10.1002/ajmg.10245, PubMed 11857561

Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH (2002)
High frequency of skewed X inactivation in young breast cancer patients
J Med Genet, 39 (1), 30-3
DOI 10.1136/jmg.39.1.30, PubMed 11826021

Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, Jeune B, Andersen-Ranberg K, Vaupel JW, Orstavik KH (2000)
X-linked genetic factors regulate hematopoietic stem-cell kinetics in females
Blood, 95 (7), 2449-51
DOI 10.1182/blood.V95.7.2449.007k06_2449_2451, PubMed 10733522

Tanner SM, Orstavik KH, Kristiansen M, Lev D, Lerman-Sagie T, Sadeh M, Liechti-Gallati S (1999)
Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother
Hum Genet, 104 (3), 249-53
DOI 10.1007/s004390050943, PubMed 10323249

Review articles

Chalabianloo F, Fadnes LT, Johansson KA, Høiseth G, Vold JH, Kringen MK, Spigset O, Bramness JG (2024)
Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications
Basic Clin Pharmacol Toxicol, 134 (3), 333-344
DOI 10.1111/bcpt.13975, PubMed 38124280

Wollmann BM, Størset E, Kringen MK, Molden E, Smith RL (2023)
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype
Eur J Clin Pharmacol, 79 (4), 523-531
DOI 10.1007/s00228-023-03462-y, PubMed 36806969

Danese E, Montagnana M, Johnson JA, Rettie AE, Zambon CF, Lubitz SA, Suarez-Kurtz G, Cavallari LH, Zhao L, Huang M, Nakamura Y, Mushiroda T, Kringen MK, Borgiani P, Ciccacci C, Au NT, Langaee T, Siguret V, Loriot MA, Sagreiya H, Altman RB, Shahin MH, Scott SA, Khalifa SI, Chowbay B et al. (2012)
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
Clin Pharmacol Ther, 92 (6), 746-56
DOI 10.1038/clpt.2012.184, PubMed 23132553